Addus HomeCare Corporation (ADUS) Stock Price & How to Invest
Last updated July 2026
Short answer
Addus HomeCare (NASDAQ: ADUS) is a home-based personal care, hospice, and home health provider that trades as a steady, profitable operator levered to aging demographics and government reimbursement. Investing in it means owning a Medicaid- and Medicare-funded services roll-up rather than a fast-growth or dividend name.
ADUS stock price
As of 2026-07-24, Addus HomeCare Corporation (ADUS) last closed at $114.55, up 4.7% over the past year. Over the past 52 weeks it has traded between $88.49 and $122.75.
Prices are daily closing prices from Yahoo Finance and may be delayed. For the live quote, check your broker or Addus HomeCare Corporation's investor relations page. Walnut is informational, not investment advice.
What does Addus HomeCare Corporation (ADUS) do?
Addus HomeCare Corporation provides in-home care to elderly, chronically ill, and disabled people through three segments: personal care (help with bathing, dressing, meals, and daily activities), hospice (end-of-life care), and home health (skilled nursing and therapy). Personal care is by far the largest piece at roughly 77% of revenue and is funded predominantly by state Medicaid programs, while hospice and home health are largely Medicare-funded. The company operates across many states with heavy concentration in markets like Illinois, New Mexico, and Texas, and has grown for years through a steady stream of acquisitions, most recently a large personal care deal that lifted 2025 revenue sharply.
The investment picture is one of defensive, demographically supported growth rather than rapid expansion. Revenue and earnings compound at mid-to-high single digits organically, supplemented by M&A, and margins are thin but stable because the business is labor-intensive and reimbursement-rate driven. The stock tends to react most to Medicaid and Medicare rate decisions, caregiver labor availability, and acquisition cadence, so the core question for an owner is confidence in the durability of government-funded home care as the population ages.
What's driving Addus HomeCare Corporation (ADUS)?
1. Aging demographics and shift to home
The 65-plus population is growing quickly and both payers and families increasingly prefer care delivered at home over institutional settings because it is cheaper and often preferred. This structural tailwind supports steady demand for Addus's personal care, hospice, and home health services over many years.
2. Personal care volume and rate growth
Personal care, roughly 77% of revenue, is growing on both higher billable hours and rising reimbursement per hour. Management has pointed to state rate support in markets like Texas, Illinois, and New Mexico plus a caregiver app that lifts hours per consumer, targeting mid-single-digit same-store growth.
3. Acquisition-led expansion
Addus has a long track record of buying regional home-care and hospice agencies and integrating them, and a recent large personal care acquisition drove 2025 revenue up more than 20%. A solid cash position and manageable debt give it room to keep consolidating a fragmented market.
4. Hospice and Medicare rate updates
The hospice segment benefits from annual Medicare rate updates and growth in average daily census, and management has framed long-term same-store hospice growth in the upper single digits. Diversifying across personal care, hospice, and home health reduces reliance on any single payer stream.
What are the risks to Addus HomeCare Corporation (ADUS)?
The largest risk is reimbursement concentration: personal care depends heavily on state Medicaid budgets and hospice and home health on Medicare, so rate cuts, budget shortfalls, or eligibility changes in key states can pressure revenue and margins directly. Proposed Medicaid or Medicare funding changes at the federal level are a recurring overhang. The business is labor-intensive, so caregiver wage inflation, turnover, and staffing shortages can squeeze already thin margins. Integration risk and the use of debt for acquisitions add execution and balance-sheet sensitivity. Finally, regulatory and compliance exposure across many states and government payers means audits, documentation requirements, and policy shifts are an ongoing part of the model.
How is Addus HomeCare Corporation (ADUS) valued? (approximate, July 2026)
A simple financial snapshot. These are approximations and refresh quarterly; for current figures see Addus HomeCare Corporation's investor relations page or your broker.
- Revenue (TTM): ~$1.44B
- FY2025 revenue: ~$1.42B (up ~23%)
- Q1 2026 revenue: ~$363.6M (up ~7.7%)
- Q1 2026 adjusted EPS: ~$1.62 (up ~14%)
- Market cap: ~$2.1B
- Trailing P/E: ~21x
Addus trades at a low-20s trailing earnings multiple, reflecting a steady, profitable services operator rather than a high-growth name. First quarter 2026 revenue of roughly $363.6 million missed some estimates while adjusted EPS beat, and net income rose about 18% year over year. The 2025 revenue jump was driven mostly by a large personal care acquisition, so underlying organic growth runs closer to mid-single digits.
Who competes with Addus HomeCare Corporation (ADUS)?
Public home health and hospice operators
Amedisys (AMED), Encompass Health (EHC), and formerly independent LHC Group (now part of UnitedHealth's Optum) compete in skilled home health and hospice. They overlap most with Addus's Medicare-funded segments rather than its Medicaid-funded personal care core.
Personal care and Medicaid-funded providers
A highly fragmented field of regional and local agencies plus players like Outreach Health, CareCentrix, and various managed-care-affiliated providers compete for state Medicaid personal care contracts, which is where most of Addus's revenue and consolidation opportunity sits.
Senior living and integrated care
Brookdale Senior Living (BKD), InnovAge (INNV), and large integrated payers moving into home-based care represent adjacent competition for the same aging population, offering facility-based or PACE-style alternatives to in-home services.
How to invest in Addus HomeCare Corporation (ADUS)
There are three common ways to get ADUS exposure. Buy shares (or fractional shares) directly at any major broker. Hold an ETF that includes it, which spreads the position across many companies. Or build it into a focused thematic basket, so ADUS sits alongside other stocks that express the same thesis.
Walnut takes the basket route. Describe a thesis where ADUS fits (for example “AI infrastructure” or “dividend-growth large-caps”) and the AI proposes 5 to 6 constituents with target weights. You review the plan and fund it through your own broker when you're ready.
New to this? Start with how to invest in stocks, see how to analyze a stock with AI, or compare the best AI stock analyzers.
The bottom line on Addus HomeCare Corporation (ADUS)
ADUS is a durable, acquisitive home-care operator whose fortunes track demographics and state/federal reimbursement policy more than product cycles.
More on Addus HomeCare Corporation (ADUS)
Whether ADUS is worth buying today depends more on your time horizon and what you already hold than on any single call. We walk through valuation, what would have to go right, and the risks in is ADUS a buy?, and where the stock could go from here in the ADUS stock forecast.
For income investors, whether ADUS pays a dividend and how the payout looks is covered in does ADUS pay a dividend?
Build a basket around ADUS with Walnut
Use Addus HomeCare Corporation as one constituent in a thematic basket Walnut's AI helps you assemble. Describe a thesis you believe in, the AI proposes the holdings and weights, and you approve before any broker order.
FAQ
What does Addus HomeCare do?
+
Addus provides in-home care through three segments: personal care (help with daily living activities), hospice (end-of-life care), and home health (skilled nursing and therapy). Personal care is the largest at roughly 77% of revenue and is funded mainly by state Medicaid programs.
How does Addus make money?
+
It bills government and managed-care payers for hours of care and days of service delivered by its caregivers and clinicians. Personal care revenue is driven by billable hours and reimbursement rates, while hospice is paid on a per-day census basis and home health on episodes of care.
Is Addus HomeCare profitable?
+
Yes. It is consistently profitable with net income growing year over year, though margins are thin because the business is labor-intensive and reimbursement-rate driven. First quarter 2026 net income rose about 18% to roughly $25 million.
What are the biggest risks for ADUS?
+
Reimbursement concentration is the main risk: personal care depends on state Medicaid budgets and hospice and home health on Medicare, so rate cuts or funding changes hit revenue directly. Caregiver wage inflation, staffing shortages, and acquisition integration add further risk.
Does Addus HomeCare pay a dividend?
+
Addus has historically prioritized reinvesting cash into acquisitions and growth rather than paying a regular dividend. Investors have generally looked to it for earnings growth rather than income; always confirm current policy with a live data source.
Why did ADUS revenue jump so much in 2025?
+
Full-year 2025 revenue rose more than 20% largely because of a large personal care acquisition that expanded its footprint. Underlying organic growth runs closer to mid-single digits, so the headline jump reflects M&A more than organic acceleration.
How is ADUS valued compared to peers?
+
As of July 2026 it trades around a low-20s trailing price-to-earnings multiple with a market cap near $2.1 billion. That reflects a steady, defensive services operator rather than a high-growth stock, and it sits alongside peers like Amedisys and Encompass Health.
How can I invest in ADUS through Walnut?
+
With Walnut you can add ADUS to a thematic basket built around a stated investment thesis, for example aging demographics or home-based healthcare, set a target weight, connect your existing brokerage, and place orders that move the basket toward those targets. Walnut is not an investment adviser and does not tell you whether to buy or sell.
Walnut is informational, not investment advice. Financial figures on this page are approximations; always verify current numbers with Addus HomeCare Corporation's investor relations page or your broker before making investment decisions.